Search Results for keywords:"Rahway New Jersey"

Found 4 results

Search Results: keywords:"Rahway New Jersey"

💰 Only
Oldest Newest
  • 2025-06283 — Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
    Type:Notice
    Citation:90 FR 15541
    Reading Time:about a minute or two

    Merck, Sharp & Dohme LLC has submitted a proposal to the Foreign-Trade Zones Board for a production activity in their Rahway, New Jersey facility, which is part of Foreign-Trade Zone 49. The proposal outlines plans to manufacture various pharmaceutical products, including drugs for infectious and neurologic diseases, oncology, immunotherapy, and cardiovascular disease, using foreign materials. Some of these materials are subject to specific trade regulations depending on their country of origin. Public comments on the proposal are welcome until May 27, 2025, and those interested in more information can contact the Board or access documents on their website.

    Simple Explanation

    Merck, Sharp & Dohme LLC wants to make medicines in a special area in Rahway, New Jersey where they can get special rules to help them bring in parts from other countries. They're asking for comments from people to tell what they think about this idea until May 27, 2025.

  • 2025-01478 — Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
    Type:Notice
    Citation:90 FR 7657
    Reading Time:less than a minute

    Merck, Sharp & Dohme LLC submitted a proposal to the Foreign-Trade Zones Board to conduct production activities at its facility in Rahway, New Jersey. The request was reviewed according to the Board's regulations, and the public was invited to comment. On January 16, 2024, the Board decided no further review was needed, and the production activity was authorized under existing regulations. The notification was officially documented on January 16, 2025.

    Simple Explanation

    Merck, a big company, got permission to make new medicine in a special area in New Jersey without extra checks because everything followed the rules. The dates seem a bit mixed up, which might be a mistake.

  • 2025-00543 — Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
    Type:Notice
    Citation:90 FR 3173
    Reading Time:about a minute or two

    Merck, Sharp & Dohme LLC has informed the Foreign-Trade Zones (FTZ) Board about proposed production activities at their Rahway, New Jersey, facility, which is part of Subzone 49Y. The proposal includes producing drugs for metabolic and immunological disorders using specific foreign-sourced materials. Interested parties can submit their comments to the FTZ Board by February 24, 2025. More details and the notification can be accessed on the Board's website.

    Simple Explanation

    Merck, Sharp & Dohme wants to make new medicines for certain illnesses in their New Jersey factory using some materials from other countries, and the government is asking anyone who is interested to tell them what they think about this plan by February 24, 2025.

  • 2025-02919 — Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
    Type:Notice
    Citation:90 FR 10048
    Reading Time:less than a minute

    Merck, Sharp & Dohme LLC submitted a request to the Foreign-Trade Zones (FTZ) Board on October 18, 2024, to start production activities at its facility in Rahway, New Jersey, which is part of FTZ Subzone 49Y. The FTZ Board reviewed this request and announced in the Federal Register that public comments on the activity were welcome. On February 18, 2025, the FTZ Board decided that no further review was necessary and approved the proposed production activities, as long as they comply with FTZ regulations. This authorization was communicated to the applicant on the same day.

    Simple Explanation

    Merck, Sharp & Dohme LLC asked for permission to make medicine-related stuff at a special zone in New Jersey where businesses get some benefits. The people in charge checked everything and said it was okay, as long as Merck follows the rules.